{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:23:43Z","timestamp":1795083823028,"version":"4.10.2"},"reference-count":37,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2010,12,15]],"date-time":"2010-12-15T00:00:00Z","timestamp":1292371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Euro J of Neurology"],"published-print":{"date-parts":[[2011,1]]},"abstract":"<jats:p><jats:bold>Background:\u2002<\/jats:bold>Utilization of antiepileptic drugs (AEDs) has long been associated with bone deleterious effects. Furthermore, the BsmI restriction fragment polymorphism of the vitamin D receptor (VDR) has been associated with reduced bone mineral density (BMD), mostly in postmenopausal women. This study evaluates the association between bone metabolism of patients with epilepsy and the BsmI VDR\u2019s polymorphism in chronic users of AEDs.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold>This study evaluated 73 long\u2010term users of antiepileptic drug monotherapy, in a cross\u2010sectional design. Fasting blood samples were obtained to estimate the circulating serum levels of calcium, magnesium, phosphorus, parathormone, 25hydroxyvitamin D as well as the VDR\u2019s genotype. Bone mineral density at the lumbar spine was measured with Dual Energy X\u2010Ray Absorptiometry.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold>Bone mineral density was significantly associated with the genotype of VDR (mean BMD: Bb genotype 1.056\u2003\u00b1\u20030.126\u2003g\/cm<jats:sup>2<\/jats:sup>; BB genotype 1.059\u2003\u00b1\u20030.113\u2003g\/cm<jats:sup>2<\/jats:sup>; bb genotype 1.179\u2003\u00b1\u20030.120\u2003g\/cm<jats:sup>2<\/jats:sup>;<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05). Additionally, the presence of at least one B allele was significantly associated with lower bone mineral density (B allele present: BMD\u2003=\u20031.057\u2003\u00b1\u20030.12\u2003g\/cm<jats:sup>2<\/jats:sup>, B allele absent: BMD\u2003=\u20031.179\u2003\u00b1\u20030.119\u2003g\/cm<jats:sup>2<\/jats:sup>;<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01). Patients with at least one B allele had lower serum levels of 25hydroxyvitamin D when compared with bb patients (22.61\u2003ng\/ml vs. 33.27\u2003ng\/ml,<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05), whilst they tended to have higher levels of parathyroid hormone.<\/jats:p><jats:p><jats:bold>Discussion:\u2002<\/jats:bold>Vitamin D receptor polymorphism is associated with lower bone mass in patients with epilepsy. This effect might be mediated through the vitamin D\u2010parathormone pathway.<\/jats:p>","DOI":"10.1111\/j.1468-1331.2010.03103.x","type":"journal-article","created":{"date-parts":[[2010,5,27]],"date-time":"2010-05-27T02:48:14Z","timestamp":1274928494000},"page":"93-98","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["BsmI vitamin D receptor\u2019s polymorphism and bone mineral density in men and premenopausal women on long\u2010term antiepileptic therapy"],"prefix":"10.1111","volume":"18","author":[{"given":"I.","family":"Lambrinoudaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Kaparos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Armeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Alexandrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Damaskos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Logothetis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Creatsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Kouskouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Triantafyllou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,12,15]]},"reference":[{"key":"e_1_2_6_2_2","unstructured":"World Health Organization; Fact sheet No 999 (2009)"},{"key":"e_1_2_6_3_2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1684\/j.1950-6945.2004.tb00053.x","article-title":"Antiepileptic drugs: indications other than epilepsy","volume":"6","author":"Spina E","year":"2004","journal-title":"Epileptic Disord"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2007.11.020"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.spen.2007.08.006"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1053\/seiz.1999.0301"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2004.02.005"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2008.03.002"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-006-0185-z"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2008.01640.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1186\/1743-7075-3-36"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/367284a0"},{"key":"e_1_2_6_13_2","first-page":"505","article-title":"Pharmacogenetics of the vitamin D receptor and osteoporosis","volume":"29","author":"Eisman JA","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2008.01716.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70352-0"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2007.02.004"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.1997.980636.x"},{"key":"e_1_2_6_18_2","first-page":"57","article-title":"The vitamin D hormone and its nuclear receptor: molecular actions and disease states","volume":"154","author":"Haussler MR","year":"1997","journal-title":"J Endocrinol"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.epirev.a018033"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010062929140"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.0301265"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650100621"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0364"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1216375"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199809000-00011"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s007740170014"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.050906"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.9.2800"},{"key":"e_1_2_6_29_2","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1681\/ASN.V8101546","article-title":"Association between vitamin D receptor gene polymorphism and relative hypoparathyroidism in patients with chronic renal failure","volume":"8","author":"Fernandez E","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03426.x"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2000.15.10.1950"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1996.492"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2003.11.029"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2003.11.011"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000324919.86696.a9"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-200X.2002.01561.x"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj3160361"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj3470321"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1331.2010.03103.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1331.2010.03103.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:52:53Z","timestamp":1740120773000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1331.2010.03103.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,15]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["10.1111\/j.1468-1331.2010.03103.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1331.2010.03103.x","archive":["Portico"],"relation":{},"ISSN":["1351-5101","1468-1331"],"issn-type":[{"value":"1351-5101","type":"print"},{"value":"1468-1331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,15]]},"assertion":[{"value":"2010-12-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}